A 6-year-old spayed female Golden Retriever collapses aft...

☠️ This is a critical situation, Doctor. A collapsed, tremoring Golden Retriever with a blood glucose of 35 mg/dL after xylitol ingestion is experiencing severe, life-threatening hypoglycemia. The mildly elevated liver enzymes indicate early liver stress, and we must aggressively manage both. Time is absolutely of the essence.

Here is the emergency treatment protocol:

Immediate Management of Hypoglycemia:

* Dextrose Bolus: Administer an immediate intravenous bolus of 0.5-1 mL/kg of 50% dextrose, diluted 1:1 with 0.9% NaCl to prevent phlebitis. This will rapidly raise the blood glucose.
* Dextrose Constant Rate Infusion (CRI): Following the bolus, initiate a continuous rate infusion of 2.5-5% dextrose in crystalloid fluids (e.g., LRS or 0.9% NaCl). The specific rate will depend on ongoing blood glucose monitoring, but typically start with a 2.5% solution at a maintenance fluid rate (e.g., 60 mL/kg/day) and adjust as needed.
* Blood Glucose Monitoring: Monitor blood glucose every 15-30 minutes initially, then hourly for at least the first 12-24 hours. The goal is to maintain blood glucose within the normal reference range (80-120 mg/dL). If hypoglycemia recurs or persists, increase the dextrose concentration or fluid rate.

Decontamination (with caveats):

* Emesis: Given the patient's collapsed and tremoring state, inducing emesis is absolutely contraindicated due to the high risk of aspiration pneumonia.
Activated Charcoal: Xylitol is poorly adsorbed by activated charcoal. However, if the ingestion was very recent (within 1-2 hours) and the patient is stable enough to protect their airway (which this patient is not currently), activated charcoal could be considered for potential co-ingestants in the gum (e.g., sugar, artificial sweeteners, gum base). In this collapsed patient, the aspiration risk outweighs the minimal benefit for xylitol. Focus on systemic management. If the patient stabilizes and the ingestion was within the last hour, and the airway can be protected, a single dose of activated charcoal at 1-2 g/kg PO might* be considered, but it is a low priority here.

Liver Protection and Monitoring:

* Hepatoprotectants: Initiate hepatoprotective agents immediately.
* N-acetylcysteine (NAC): Administer a loading dose of 140 mg/kg PO or IV, followed by 70 mg/kg q4-6h for 7 doses. NAC helps replete glutathione stores, critical for hepatic detoxification.
* S-Adenosylmethionine (SAMe): While not in the verified formulary for specific doses, SAMe is a common hepatoprotectant (typically 18-20 mg/kg PO q24h) and should be considered.
* Liver Enzyme Monitoring: Monitor liver enzymes (ALT, ALP, bilirubin) at 24, 48, and 72 hours post-ingestion. Significant increases indicate developing hepatotoxicity, which carries a guarded to poor prognosis.
* IV Fluids: Maintain aggressive intravenous fluid therapy (beyond the dextrose CRI) to support renal perfusion and aid in toxin excretion.

Supportive Care and Monitoring:

* Neurological Monitoring: Closely monitor for tremors, seizures, and mental status changes. If seizures occur, administer diazepam 0.5-1 mg/kg IV to effect.
* Electrolytes and Acid-Base: Monitor electrolytes (especially potassium) and acid-base status (blood gas) regularly, as severe hypoglycemia and liver compromise can lead to imbalances.
* Thermal Support: Maintain normothermia, as hypoglycemia can cause hypothermia.

Prognosis:
The prognosis for xylitol toxicosis is generally good if only hypoglycemia occurs and is treated promptly and aggressively. However, the development of liver failure significantly worsens the prognosis, making it guarded to poor. Early and aggressive intervention as outlined above is crucial to mitigate liver damage and stabilize the patient.

This patient requires immediate hospitalization and intensive care. Ensure all staff are aware of the ongoing monitoring requirements for blood glucose and potential liver complications.